QIAGEN Welcomes New Guidelines from American Academy of Pediatrics for Detecting Tuberculosis Infection in Children
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Business Wire
Modern blood tests such as QuantiFERON-TB now recommended for patients ages 2 to 18 GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines from the American Academy of Pediatrics (AAP) that recommend screening at-risk children as young as two years old for latent tuberculosis (TB) infection. The AAP guidelines include recommendations regarding testing with interferon gamma release assays (IGRAs) such as QIAGEN’s QuantiFERON-TB Gold (QFT) or QuantiFERON-TB Gold Plus (QFT-Plus). The new standards were published June 1st in the association’s Red Book: 2018 Report of the Committee on Infectious Diseases. The pediatric guidelines come as authorities around the world are expanding the role of latent TB screening in global tuberculosis control efforts. For example, the World Health Organization (WHO) re
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Cervical Dysplasia Market Report 2024: Global Trends, Forecast and Competitive Analysis 2018-2023 and 2024-2030 [Yahoo! Finance]Yahoo! Finance
- U.S. Next Generation Sequencing Market Analysis Report 2024-2030: Consumables Dominated the Product Segment in 2023, Owing to the Increasing Demand for High-quality and Reliable Sequencing Products [Yahoo! Finance]Yahoo! Finance
- Global Infectious Disease In vitro Diagnostics Analysis Report 2024: An $80+ Billion Market in 2030 - Investment in Education and Training and Leveraging Artificial Intelligence for Advancements [Yahoo! Finance]Yahoo! Finance
- Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028 [Yahoo! Finance]Yahoo! Finance
- Global Protein Expression Market Outlook 2024-2034: North America and APAC Set for Rapid Expansion [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 2/6/24 - Miss
QGEN
Sec Filings
- 3/11/24 - Form 20-F
- 3/11/24 - Form IRANNOTICE
- 2/9/24 - Form SC
- QGEN's page on the SEC website